These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L, Cai K, Wang K, Luo Q. J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [Abstract] [Full Text] [Related]
23. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Chen SF, Wang H, Huang YM, Li ZY, Wang SX, Yu F, Zhao MH, Chen M. Clin J Am Soc Nephrol; 2015 May 07; 10(5):750-8. PubMed ID: 25749534 [Abstract] [Full Text] [Related]
24. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature. Van Gool IC, Kers J, Bakker JA, Rotmans JI, Teng YKO, Bauer MP. Clin Rheumatol; 2022 Oct 07; 41(10):2949-2960. PubMed ID: 35732985 [Abstract] [Full Text] [Related]
25. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis. Sparding N, Genovese F, Rasmussen DGK, Karsdal MA, Neprasova M, Maixnerova D, Satrapova V, Frausova D, Hornum M, Bartonova L, Honsova E, Kollar M, Koprivova H, Hruskova Z, Tesar V. Nephrol Dial Transplant; 2022 May 25; 37(6):1099-1108. PubMed ID: 33914059 [Abstract] [Full Text] [Related]
26. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Winters MJ, Hurley RM, Lirenman DS. Pediatr Nephrol; 2002 Apr 25; 17(4):257-60. PubMed ID: 11956877 [Abstract] [Full Text] [Related]
27. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis]. Guan N, Yao Y, Yang JY, Xiao HJ, Ding J. Zhonghua Er Ke Za Zhi; 2013 Apr 25; 51(4):283-7. PubMed ID: 23927802 [Abstract] [Full Text] [Related]
28. Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? Ahn SS, Ha JW, Park YB, Lee SW. Rheumatology (Oxford); 2022 Apr 11; 61(4):1366-1375. PubMed ID: 34320628 [Abstract] [Full Text] [Related]
29. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis. Hakroush S, Tampe D, Ströbel P, Korsten P, Tampe B. Front Immunol; 2021 Apr 11; 12():737708. PubMed ID: 34759920 [Abstract] [Full Text] [Related]
30. [Clinicopathologic analysis of 34 patients with microscopic polyangitis]. Xuan XF, Wu HJ, Liu Y, Zhao ZH, Hong FY, Wang YX, Zhang ZG, Guo MY. Zhonghua Bing Li Xue Za Zhi; 2007 Nov 11; 36(11):746-50. PubMed ID: 18307878 [Abstract] [Full Text] [Related]
31. Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series. Bantis C, Stangou M, Schlaugat C, Alexopoulos E, Pantzaki A, Memmos D, Ivens K, Heering PJ. Am J Kidney Dis; 2010 Feb 11; 55(2):259-68. PubMed ID: 20042261 [Abstract] [Full Text] [Related]
32. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study. Minz RW, Chhabra S, Joshi K, Rani L, Sharma N, Sakhuja V, Duggal R, Pasricha N. Indian J Pathol Microbiol; 2012 Feb 11; 55(1):28-32. PubMed ID: 22499296 [Abstract] [Full Text] [Related]
33. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients. Hu X, Shen C, Meng T, Ooi JD, Eggenhuizen PJ, Zhou YO, Luo H, Chen JB, Lin W, Gong Y, Xiong Q, Xu J, Liu N, Xiao X, Tang R, Zhong Y. Front Immunol; 2022 Feb 11; 13():991469. PubMed ID: 36389826 [Abstract] [Full Text] [Related]
34. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with rheumatoid arthritis: a comparison of patients without rheumatoid arthritis. Kurita N, Mise N, Fujii A, Mori M, Sai K, Nishi T, Suzuki T, Tagawa H, Sugimoto T. Clin Exp Nephrol; 2010 Aug 11; 14(4):325-32. PubMed ID: 20339893 [Abstract] [Full Text] [Related]
35. Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study. Kim JY, Choi H, Kim MK, Lee SB, Park YB, Lee SW. Rheumatol Int; 2019 Nov 11; 39(11):1927-1936. PubMed ID: 31372719 [Abstract] [Full Text] [Related]
36. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Tian S, Yang X, Luo J, Guo H. Int Immunopharmacol; 2020 Nov 11; 88():106896. PubMed ID: 33182045 [Abstract] [Full Text] [Related]
37. C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis. Korsten P, Baier E, Hakroush S, Tampe B. Int J Mol Sci; 2023 Feb 04; 24(4):. PubMed ID: 36834488 [Abstract] [Full Text] [Related]
38. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity. Baier E, Tampe D, Kluge IA, Hakroush S, Tampe B. Front Immunol; 2022 Feb 04; 13():1054457. PubMed ID: 36439156 [Abstract] [Full Text] [Related]
39. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report. Li XL, Xu PC, Chen T, Yan TK, Jiang JQ, Jia JY, Wei L, Shang WY, Hu SY. Medicine (Baltimore); 2017 Dec 04; 96(51):e9128. PubMed ID: 29390440 [Abstract] [Full Text] [Related]
40. Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians. Gaumond L, Lamarche C, Beauchemin S, Henley N, Elftouh N, Gerarduzzi C, Laurin LP. Inflamm Res; 2024 Mar 04; 73(3):447-457. PubMed ID: 38291238 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]